MEA Flow Cytometry Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143313
- Pages: 225
-
Format:
Short Description
Middle East and Africa Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales), Country (South Africa, U.A.E, Saudi Arabia, Egypt, and Rest of the Middle East and Africa), Industry Trends and Forecast to 2029
Market Definition:
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
Most frequently used for analyzing peripheral blood, bone marrow, and other bodily fluids, flow cytometry offers a tried-and-true approach to identifying cells in solution. Flow cytometry studies are used to define hematological malignancies and identify and count immune cells. Fluorescent probes are used in flow cytometry to identify and describe cells or particles. Applications for flow cytometry include live/dead bacterial discrimination, membrane potential, immunophenotyping, transfection efficiency, apoptosis measurement, cell cycle analysis, fluorescent intensity, cell proliferation, cell sorting, and many more. Flow cytometry has a broad range of applications for research and clinical purposes, including cancer diagnosis, chromosome identification, and protein expression.
Flow cytometry is a technology that provides rapid multi-parametric analysis of single cells in solution. They utilize lasers as a light source and produce scattered and fluorescent light signals that get detected by detectors such as photodiodes or photomultiplier tubes attached to the cytometer.
Market Segmentation:
The Middle East and Africa flow cytometry market is categorized into five notable segments based on product, technology, application, end user, and distribution channel.
On the basis of product, the Middle East and Africa flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services
On the basis of technology, the Middle East and Africa flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry
On the basis of application, the Middle East and Africa flow cytometry market is segmented into research applications, clinical applications, and industrial applications
On the basis of end user, the Middle East and Africa flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others
On the basis of distribution channel, the Middle East and Africa flow cytometry market is segmented into direct tenders and retail sales
Market Players
Some of the major players operating in the Middle East and Africa flow cytometry market are:
Thermo Fisher Scientific Inc.
BD
Luminex Corporation (now subsidiary of DiaSorin S.p.A.)
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
bioMrieux SA
Merck KGaA
Enzo Biochem Inc.
Takara Bio Inc.
Sartorius AG
Q2 Solutions (a Subsidiary of IQVIA)
Elabscience Biotechnology Inc.
ORFLO Technologies
TABLE OF CONTENTS
1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET 38
1.4 LIMITATIONS 40
1.5 MARKETS COVERED 41
2 MARKET SEGMENTATION 44
2.1 MARKETS COVERED 44
2.2 GEOGRAPHICAL SCOPE 45
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 CURRENCY AND PRICING 46
2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
2.6 MULTIVARIATE MODELLING 50
2.7 PRODUCT SEGMENT LIFELINE CURVE 50
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.9 DBMR MARKET POSITION GRID 52
2.10 MARKET APPLICATION COVERAGE GRID 53
2.11 VENDOR SHARE ANALYSIS 54
2.12 SECONDARY SOURCES 55
2.13 ASSUMPTIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 60
4.1 PORTERS FIVE FORCES 61
5 MARKET OVERVIEW 62
5.1 DRIVERS 64
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES 64
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 65
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 66
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES 67
5.2 RESTRAINTS 67
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 67
5.2.2 LIMITATIONS OF FLOW CYTOMETRY 68
5.2.3 LACK OF SKILLED PROFESSIONALS 69
5.3 OPPORTUNITIES 69
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 69
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 70
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 71
5.3.4 DEVELOPING PIPELINE OF STEM CELL RESEARCH 71
5.4 CHALLENGES 72
5.4.1 DIFFICULTY IN DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 72
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 72
6 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY PRODUCT 74
6.1 OVERVIEW 75
6.2 REAGENTS AND CONSUMABLES 78
6.2.1 DYE 79
6.2.2 ANTIBODIES 79
6.2.3 BEADS 79
6.2.4 OTHERS 79
6.3 FLOW CYTOMETRY INSTRUMENTS 79
6.3.1 CELL ANALYZERS 81
6.3.1.1 CELL ANALYZERS, BY TYPE 81
6.3.1.1.1 IMAGING FLOW CYTOMETERS 81
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 81
6.3.1.2 CELL ANALYZERS, BY MODALITY 81
6.3.1.2.1 BENCHTOP 82
6.3.1.2.2 STANDALONE 82
6.3.2 CELL SORTERS 82
6.3.2.1 BENCHTOP 82
6.3.2.2 STANDALONE 82
6.4 ACCESSORIES 82
6.4.1 FILTERS 84
6.4.2 DETECTORS 84
6.4.3 OTHERS 84
6.5 SERVICES 84
6.6 SOFTWARE 85
7 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY 86
7.1 OVERVIEW 87
7.2 CELL-BASED FLOW CYTOMETRY 90
7.3 BEAD-BASED FLOW CYTOMETRY 90
8 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY APPLICATION 92
8.1 OVERVIEW 93
8.2 RESEARCH APPLICATIONS 96
8.2.1 CELL CYCLE ANALYSIS 97
8.2.2 CELL SORTING/SCREENING 97
8.2.3 CELL TRANSFECTION/VIABILITY 97
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 98
8.2.4.1 DRUG DISCOVERY 98
8.2.4.2 STEM CELL RESEARCH 98
8.2.4.3 IN VITRO TOXICITY TESTING 98
8.2.5 IMMUNOLOGY 98
8.2.6 APOPTOSIS 98
8.2.7 CELL COUNTING 98
8.2.8 OTHERS 98
8.3 CLINICAL APPLICATIONS 99
8.3.1 HAEMATOLOGY 100
8.3.2 CANCER 100
8.3.3 IMMUNODEFICIENCY DISEASES 100
8.3.4 ORGAN TRANSPLANTATION 100
8.3.5 OTHER CLINICAL APPLICATION 100
8.4 INDUSTRIAL APPLICATIONS 101
9 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY END USER 102
9.1 OVERVIEW 103
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES 106
9.3 ACADEMIC & RESEARCH INSTITUTES 107
9.4 HOSPITALS 108
9.5 CLINICAL TESTING LABORATORIES 109
9.6 BLOOD BANK 110
9.7 OTHERS 111
10 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 112
10.1 OVERVIEW 113
10.2 RETAIL SALES 116
10.3 DIRECT TENDERS 117
11 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY REGION 118
11.1 MIDDLE EAST & AFRICA 119
11.1.1 SOUTH AFRICA 128
11.1.2 SAUDI ARABIA 132
11.1.3 U.A.E 136
11.1.4 EGYPT 140
11.1.5 REST OF MIDDLE EAST & AFRICA 144
12 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET: COMPANY LANDSCAPE 145
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 145
13 SWOT ANALYSIS 146
14 COMPANY PROFILE 147
14.1 THERMO FISHER SCIENTIFIC INC. (2021) 147
14.1.1 COMPANY SNAPSHOT 147
14.1.2 REVENUE ANALYSIS 147
14.1.3 COMPANY SHARE ANALYSIS 148
14.1.4 PRODUCT PORTFOLIO 148
14.1.5 RECENT DEVELOPMENTS 149
14.1.5.1 ACQUISITION 149
14.2 BD (2021) 151
14.2.1 COMPANY SNAPSHOT 151
14.2.2 REVENUE ANALYSIS 151
14.2.3 COMPANY SHARE ANALYSIS 152
14.2.4 PRODUCT PORTFOLIO 152
14.2.5 RECENT DEVELOPMENT 153
14.2.5.1 COLLABORATION 153
14.3 AGILENT TECHNOLOGIES, INC. (2021) 154
14.3.1 COMPANY SNAPSHOT 154
14.3.2 REVENUE ANALYSIS 154
14.3.3 COMPANY SHARE ANALYSIS 155
14.3.4 PRODUCT PORTFOLIO 155
14.3.5 RECENT DEVELOPMENT 157
14.3.5.1 ACQUISITION 157
14.4 LUMINEX CORPORATION (NOW SUBSIDIARY OF DIASORIN S.P.A.) 158
14.4.1 COMPANY SNAPSHOT 158
14.4.2 COMPANY SHARE ANALYSIS 158
14.4.3 PRODUCT PORTFOLIO 159
14.4.4 RECENT DEVELOPMENTS 161
14.4.4.1 PRODUCT LAUNCH 161
14.5 SARTORIUS AG (2021) 162
14.5.1 COMPANY SNAPSHOT 162
14.5.2 REVENUE ANALYSIS 162
14.5.3 COMPANY SHARE ANALYSIS 163
14.5.4 PRODUCT PORTFOLIO 163
14.5.5 RECENT DEVELOPMENTS 164
14.6 BAY BIOSCIENCE CO., LTD. 165
14.6.1 COMPANY SNAPSHOT 165
14.6.2 PRODUCT PORTFOLIO 165
14.6.3 RECENT DEVELOPMENT 165
14.7 BIOMRIEUX SA (2021) 166
14.7.1 COMPANY SNAPSHOT 166
14.7.2 REVENUE ANALYSIS 166
14.7.3 PRODUCT PORTFOLIO 167
14.7.4 RECENT DEVELOPMENT 167
14.8 Q2 SOLUTION (A SUBSIDIARY OF IQVIA) 168
14.8.1 COMPANY SNAPSHOT 168
14.8.2 REVENUE ANALYSIS 168
14.8.3 SERVICE PORTFOLIO 169
14.8.4 RECENT DEVELOPMENT 169
14.9 TAKARA BIO INC. (2021) 170
14.9.1 COMPANY SNAPSHOT 170
14.9.2 REVENUE ANALYSIS 170
14.9.3 PRODUCT PORTFOLIO 171
14.9.4 RECENT DEVELOPMENTS 171
14.10 APOGEE FLOW SYSTEMS LTD. 172
14.10.1 COMPANY SNAPSHOT 172
14.10.2 PRODUCT PORTFOLIO 172
14.10.3 RECENT DEVELOPMENT 172
14.10.3.1 PRODUCT LAUNCH 172
14.11 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) (2021) 173
14.11.1 COMPANY SNAPSHOT 173
14.11.2 REVENUE ANALYSIS 173
14.11.3 PRODUCT PORTFOLIO 174
14.11.4 RECENT DEVELOPMENTS 175
14.11.4.1 ACQUISITION 175
14.11.4.2 PRODUCT LAUNCH 176
14.12 BENNUBIO INC. 177
14.12.1 COMPANY SNAPSHOT 177
14.12.2 PRODUCT PORTFOLIO 177
14.12.3 RECENT DEVELOPMENTS 177
14.13 BIOLEGEND, INC. 178
14.13.1 COMPANY SNAPSHOT 178
14.13.2 PRODUCT PORTFOLIO 178
14.13.3 RECENT DEVELOPMENT 180
14.13.3.1 ACQUISITION 180
14.14 BIO-RAD LABORATORIES, INC. (2021) 182
14.14.1 COMPANY SNAPSHOT 182
14.14.2 REVENUE ANALYSIS 182
14.14.3 PRODUCT PORTFOLIO 183
14.14.4 RECENT DEVELOPMENT 183
14.15 CELL SIGNALING TECHNOLOGY, INC. 184
14.15.1 COMPANY SNAPSHOT 184
14.15.2 PRODUCT PORTFOLIO 184
14.15.3 RECENT DEVELOPMENT 185
14.16 CELLKRAFT BIOTECH PVT. LTD 186
14.16.1 COMPANY SNAPSHOT 186
14.16.2 PRODUCT PORTFOLIO 186
14.16.3 RECENT DEVELOPMENT 187
14.17 CYTEK BIOSCIENCES (2021) 188
14.17.1 COMPANY SNAPSHOT 188
14.17.2 PRODUCT PORTFOLIO 188
14.17.3 RECENT DEVELOPMENTS 189
14.17.3.1 PRODUCT LAUNCH 189
14.17.3.2 ACQUISITION 189
14.18 CYTOBUOY B.V. 191
14.18.1 COMPANY SNAPSHOT 191
14.18.2 PRODUCT PORTFOLIO 191
14.18.3 RECENT DEVELOPMENT 191
14.19 CYTONOME/ST, LLC 192
14.19.1 COMPANY SNAPSHOT 192
14.19.2 PRODUCT PORTFOLIO 192
14.19.3 RECENT DEVELOPMENTS 192
14.20 ELABSCIENCE BIOTECHNOLOGY INC. 193
14.20.1 COMPANY SNAPSHOT 193
14.20.2 PRODUCT PORTFOLIO 193
14.20.3 RECENT DEVELOPMENT 194
14.21 ENZO BIOCHEM INC. 195
14.21.1 COMPANY SNAPSHOT 195
14.21.2 REVENUE ANALYSIS 195
14.21.3 PRODUCT PORTFOLIO 196
14.21.4 RECENT DEVELOPMENTS 196
14.22 II-VI INCORPORATED (2021) 197
14.22.1 COMPANY SNAPSHOT 197
14.22.2 REVENUE ANALYSIS 197
14.22.3 PRODUCT PORTFOLIO 198
14.22.4 RECENT DEVELOPMENTS 198
14.22.4.1 PRODUCT LAUNCH 198
14.22.4.2 AWARDS 198
14.23 IKEDA SCIENTIFIC CO., LTD. 200
14.23.1 COMPANY SNAPSHOT 200
14.23.2 PRODUCT PORTFOLIO 200
14.23.3 RECENT DEVELOPMENT 201
14.24 MERCK KGAA (2021) 202
14.24.1 COMPANY SNAPSHOT 202
14.24.2 REVENUE ANALYSIS 202
14.24.3 PRODUCT PORTFOLIO 203
14.24.4 RECENT DEVELOPMENTS 203
14.24.4.1 COLLABORATION/ AGREEMENT 203
14.25 MILTENYI BIOTEC 205
14.25.1 COMPANY SNAPSHOT 205
14.25.2 PRODUCT PORTFOLIO 205
14.25.3 RECENT DEVELOPMENTS 206
14.25.3.1 PRODUCT LAUNCH 206
14.26 NANOCELLECT BIOMEDICAL 208
14.26.1 COMPANY SNAPSHOT 208
14.26.2 PRODUCT PORTFOLIO 208
14.26.3 RECENT DEVELOPMENTS 208
14.27 NEOGENOMICS LABORATORIES (2021) 210
14.27.1 COMPANY SNAPSHOT 210
14.27.2 REVENUE ANALYSIS 210
14.27.3 PRODUCT PORTFOLIO 211
14.27.4 RECENT DEVELOPMENT 211
14.28 NEXCELOM BIOSCIENCE LLC 212
14.28.1 COMPANY SNAPSHOT 212
14.28.2 PRODUCT PORTFOLIO 212
14.28.3 RECENT DEVELOPMENTS 212
14.29 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION 214
14.29.1 COMPANY SNAPSHOT 214
14.29.2 PRODUCT PORTFOLIO 214
14.29.3 RECENT DEVELOPMENTS 214
14.30 ORFLO TECHNOLOGIES 215
14.30.1 COMPANY SNAPSHOT 215
14.30.2 PRODUCT PORTFOLIO 215
14.30.3 RECENT DEVELOPMENT 216
14.30.3.1 COLLABORATION 216
14.31 SONY BIOTECHNOLOGY INC. 217
14.31.1 COMPANY SNAPSHOT 217
14.31.2 PRODUCT PORTFOLIO 217
14.31.3 RECENT DEVELOPMENT 220
14.32 STRATEDIGM, INC 221
14.32.1 COMPANY SNAPSHOT 221
14.32.2 PRODUCT PORTFOLIO 221
14.32.3 RECENT DEVELOPMENTS 221
14.33 SYSMEX CORPORATION (2021) 222
14.33.1 COMPANY SNAPSHOT 222
14.33.2 REVENUE ANALYSIS 222
14.33.3 PRODUCT PORTFOLIO 223
14.33.4 RECENT DEVELOPMENT 223
14.33.4.1 ACQUISITION 223
14.34 UNION BIOMETRICA, INC. 224
14.34.1 COMPANY SNAPSHOT 224
14.34.2 PRODUCT PORTFOLIO 224
14.34.3 RECENT DEVELOPMENTS 224
15 QUESTIONNAIRE 226
16 RELATED REPORTS 229
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
